scispace - formally typeset
M

Myles R. Minter

Researcher at University of Melbourne

Publications -  12
Citations -  1390

Myles R. Minter is an academic researcher from University of Melbourne. The author has contributed to research in topics: JAK-STAT signaling pathway & Interferon. The author has an hindex of 11, co-authored 12 publications receiving 960 citations. Previous affiliations of Myles R. Minter include University of Chicago.

Papers
More filters
Journal ArticleDOI

Antibiotic-induced perturbations in gut microbial diversity influences neuro-inflammation and amyloidosis in a murine model of Alzheimer’s disease

TL;DR: It is shown that prolonged shifts in gut microbial composition and diversity induced by long-term broad-spectrum combinatorial antibiotic treatment regime decreases Aβ plaque deposition and attenuated plaque-localised glial reactivity in these mice and significantly altered microglial morphology.
Journal ArticleDOI

The contribution of neuroinflammation to amyloid toxicity in Alzheimer's disease

TL;DR: Evidence supporting the combined neuroinflammatory‐amyloid hypothesis for pathogenesis of AD is described, describing the key cell types, pathways and mediators involved.
Journal ArticleDOI

Antibiotic-induced perturbations in microbial diversity during post-natal development alters amyloid pathology in an aged APP SWE /PS1 ΔE9 murine model of Alzheimer’s disease

TL;DR: It is shown that early post-natal ABX treatment results in long-term alterations of gut microbial genera and reduction in brain Aβ deposition in aged APPSWE/PS1ΔE9 mice and it is confirmed that plaque-localised microglia and astrocytes are reduced in ABX-exposed mice.
Journal ArticleDOI

Type-1 interferon signaling mediates neuro-inflammatory events in models of Alzheimer's disease

TL;DR: A role for type-1 interferons in the pro-inflammatory response and neuronal cell death in AD is supported and blocking type- 1 interferon-α receptor 1 maybe a therapeutic target to limit the disease progression is suggested.
Journal ArticleDOI

Cell-targetable DNA nanocapsules for spatiotemporal release of caged bioactive small molecules

TL;DR: This work combines a cell-targetable, icosahedral DNA-nanocapsule loaded with photoresponsive polymers with sequestration inside the DNA capsule to release dehydroepiandrosterone (DHEA), a neurosteroid that promotes neurogenesis and neuron survival, and determined the timescale of neuronal activation by DHEA.